1. Shin DW, Kim YI, Kim SJ, Kim JS, Chong S, Park YS, Song SY, Lee JH, Ahn HK, Kim EY, Yang SH, Lee MK, Cho DG, Jang TW, Son JW, Ryu JS, Cho MJ. Lung cancer specialist physicians' attitudes towards e-cigarettes: A nationwide survey. PLoS One. 2017 Feb 24;12(2)

2. Park CK, Oh IJ, Kim KS, Choi YD, Jang TW, Kim YS, Lee KH, Shin KC, Jung CY, Yang SH, Ryu JS, Jang SH, Yoo SS, Yong SJ, Lee KY, In KH, Lee MK, Kim YC. Randomized Phase III Study of Docetaxel Plus Cisplatin Versus Pemetrexed Plus Cisplatin as First-line Treatment of Nonsquamous Non-Small-cell Lung Cancer: A TRAIL Trial. Clin Lung Cancer. 2017 Jul;18(4)

3. Oh IJ, Kim KS, Park CK, Kim YC, Lee KH, Jeong JH, Kim SY, Lee JE, Shin KC, Jang TW, Lee HK, Lee KY, Lee SY. BMC Cancer. Belotecan/cisplatin versus etoposide/cisplatin in previously untreated patients with extensive-stage small cell lung carcinoma: a multi-center randomized phase III trial.2016 Aug 26;16:690.

4. Nam SJ, Jeong JY, Jang TW, Jung MH, Chun BK, Cha HJ, Oak CH. Neuron-specific enolase as a novel biomarker reflecting tuberculosis activity and treatment response. Korean J Intern Med. 2016 Jul;31(4):694-702